Testa, S <br/><br/>
Low drug levels and thrombotic complications in high-risk atrial fibrillation patients treated with direct oral anticoagulants.  [electronic resource] 

 -  Journal of thrombosis and haemostasis : JTH  05 2018 
 - 842-848 p.  digital 
<br/><br/> Publication Type: Journal Article; Multicenter Study; Observational Study 
<br/><br/><label>ISSN: </label>1538-7836 
<br/><br/><label>Standard No.: </label>10.1111/jth.14001  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Administration, Oral<br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Antithrombins--administration & dosage<br/>Atrial Fibrillation--blood<br/>Blood Coagulation Tests<br/>Dabigatran--administration & dosage<br/>Drug Monitoring--methods<br/>Factor Xa Inhibitors--administration & dosage<br/>Female<br/>Humans<br/>Male<br/>Middle Aged<br/>Predictive Value of Tests<br/>Preliminary Data<br/>Pyrazoles--administration & dosage<br/>Pyridones--administration & dosage<br/>Registries<br/>Risk Assessment<br/>Risk Factors<br/>Rivaroxaban--administration & dosage<br/>Thromboembolism--blood<br/>Time Factors<br/>Treatment Outcome